The two faces of interleukin 12: a pro-inflammatory cytokine and a key immunoregulatory molecule produced by antigen-presenting cells.

The two faces of interleukin 12: a pro-inflammatory cytokine and a key immunoregulatory molecule produced by antigen-presenting cells.
复制标题

DOI:
10.1002/9780470514849.ch14
复制
发表时间:
1995
期刊:
Ciba Foundation symposium
影响因子:
--
通讯作者:
G. Trinchieri
G. Trinchieri
中科院分区:
其他
文献类型:
--
作者:
G. Trinchieri

文献摘要

被引文献

相似文献

白细胞介素12(IL-12)由吞噬细胞、抗原呈递细胞和B淋巴细胞响应细菌或细胞内寄生虫而产生。IL-12作用于T和自然杀伤(NK)细胞,诱导:细胞因子,特别是γ-干扰素(IFN-γ)的产生;增殖;和细胞介导的细胞毒性的增强。在感染早期,IL-12作为促炎细胞因子并诱导NK和T细胞产生IFN-γ。IFN-γ激活吞噬细胞并增加其产生IL-12的能力。与IFN-γ不同,IL-10、IL-4、IL-13和转化生长因子β是IL-12的产生和活性的负调节剂。IL-12通过刺激T辅助1(Th 1)细胞的产生为随后的适应性免疫应答奠定基础。IL-12(有利于Th 1应答)和IL-4(有利于Th 2应答)之间的平衡可能决定了免疫应答期间Th 1/Th 2二分法的最终结果。HIV感染患者即使在疾病的早期阶段也缺乏IL-12的产生。然而,外源性IL-12可以在体外改善这些患者的T和NK细胞的免疫应答性缺陷,这表明IL-12缺陷在HIV疾病发病机制中的可能作用以及IL-12对机会性病原体和HIV感染本身的潜在治疗作用。
Interleukin 12 (IL-12) is produced by phagocytic cells, antigen-presenting cells and B lymphocytes in response to bacteria or intracellular parasites. IL-12 acts on T and natural killer (NK) cells inducing: production of cytokines, particularly gamma-interferon (IFN-gamma); proliferation; and enhancement of cell-mediated cytotoxicity. Early in infection, IL-12 acts as a proinflammatory cytokine and induces IFN-gamma production by NK and T cells. IFN-gamma activates the phagocytes and increases their ability to produce IL-12. Unlike IFN-gamma, IL-10, IL-4, IL-13 and transforming growth factor beta are negative regulators of the production and activity of IL-12. IL-12 sets the stage for the ensuing adaptive immune response by stimulating the generation of T helper 1 (Th1) cells. It is likely that the balance between IL-12 (favouring a Th1 response) and IL-4 (favouring a Th2 response) determines the eventual outcome of the Th1/Th2 dichotomy during an immune response. HIV-infected patients have a deficient production of IL-12, even at early stages of the disease. However, exogenous IL-12 can improve the deficient immune responsiveness of these patients' T and NK cells in vitro, suggesting a possible role of the IL-12 deficiency in HIV disease pathogenesis and a potential therapeutic role of IL-12 both against opportunistic pathogens and HIV infection itself.